Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-014861
Filing Date
2019-10-25
Accepted
2019-10-25 10:39:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 33920
2 filename2.txt TEXT-EXTRACT 3513
  Complete submission text file 0000000000-19-014861.txt   50964
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filed for) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations